We present a unique case of a cavernous sinus (CS) dural arteriovenous fi stula (DAVF), which recurred at adjacent sinuses following repeated transvenous embolizations (TVEs). A 68-year-old woman presented with progressive left conjunctival chemosis and diplopia. Cerebral angiography revealed a left CS DAVF, which was completely obliterated by TVE via the left inferior petrosal sinus (IPS). Two years later, the DAVF recurred in the left IPS, and again in the left sigmoid sinus (SS) 3 years after the initial treatment in spite of a second TVE. Moreover, the left SS and the left internal jugular vein, which had been previously stenotic, had been occluded. The third TVE resulted in the complete obliteration of the SS DAVF. CS DAVFs may recur at adjacent sinuses even after complete obliteration by TVE. Careful followup is necessary to check for the recurrence of DAVFs, especially in cases with venous fl ow changes, such as sinus occlusion, following endovascular treatment.
Introduction
Dural arteriovenous fi stulas (DAVFs) comprise 10%-15% of intracranial arteriovenous malformations. 1 Among them, multiple DAVFs have an incidence of 7%. 2 Although a DAVF is generally thought to be an acquired lesion, its pathogenesis has not yet been established. The treatment strategy is based on angiographic features including feeding arteries and venous drainage, location of the fi stula, severity of presenting symptoms, and the patient's condition. 3 At present, transvenous embolization (TVE) has been widely accepted as a useful treatment for DAVFs. 4 Anatomical obliteration rates with TVE have been reported to range from 63% to 87.5% and the clinical cure rates from 83% to 96%. [5] [6] [7] [8] [9] [10] However, some reports have demonstrated an appearance of a new DAVF following endovascular treatment. 4, [11] [12] [13] [14] [15] [16] We herein present a case of a cavernous sinus (CS) DAVF that recurred in the ipsilateral inferior petrosal sinus (IPS) and then in the sigmoid sinus (SS), in spite of repeated TVEs, and discuss the mechanism of a recurrence of the DAVF.
Case report
A 68-year-old woman was admitted to our hospital because of a 6-month history of progressive left conjunctival chemosis and diplopia. The patient did not have any history of head injury, intracranial surgery, or intake of female hormones. Cerebral angiography and magnetic resonance (MR) three-dimensional spoiled gradient-recalled acquisition (3D-SPGR) images showed a left CS DAVF, which was fed by the bilateral internal and the external carotid arteries (Barrow type D; num coils (Vortex; Boston Scientifi c, Fremont, CA, USA). Total number of coils was 22. The DAVF was completely obliterated without changing venous fl ow patterns ( Fig. 1D-F) .The patient's clinical symptoms were markedly improved, and she was discharged without any neurological defi cits.
Two years after the initial treatment, the patient presented with progressive left tinnitus. Cerebral angiography and MR 3D-SPGR images showed a recurrence of the DAVF in the left IPS ( Fig. 2A-C ). She underwent a second TVE because of progressive symptoms. The left IPS was embolized using GDC (total number, 7), and the DAVF disappeared completely (Fig. 2D) . At the end of the procedure, the venous fl ow through the left transverse sinus-sigmoid sinus (TS-SS) was found to be much slower than before (Fig. 2E ). Three years after the fi rst TVE, the patient again presented with progressive left tinnitus. Cerebral angiography showed a recurrence of the DAVF in the left SS (Fig.  3A,B) without refl ux of cortical veins (Cognard type IIa). Moreover, the left SS and the left jugular vein, which had been previously stenotic, had been occluded (Fig. 3C) . A third TVE was undertaken for the left SS DAVF via the right internal jugular vein using detachable coils (GDC and Trufi ll DCS; Cordis, Miami, FL, USA), which resulted in a complete obliteration (Fig.  3D ). There has been no recurrence of the DAVF during the 2-year follow-up after the third treatment.
Discussion
A variety of modalities have been applied to treat DAVFs, including endovascular procedures, 9,17,18 direct sinus packing, 19 surgical interruption of the draining veins, 19 gamma-knife surgery, 20 and combinations of these treatments. 21, 22 Among them, TVE has been widely accepted as an effective treatment. [5] [6] [7] [8] [9] [10] 23 However, seven cases demonstrating a new DAVF following endovascular treatments have been reported (Table 1) . 4, [11] [12] [13] [14] [15] [16] In these DAVFs, new lesions occurred in either the ipsilateral TS-SS or the jugular vein. TVE was performed in four cases, TVE with transarterial embolization (TAE) in two cases, and TAE in one case, respectively. Catheterization to the IPS was performed in six cases. It is noteworthy that sinus occlusion after the treatment occurred in two cases. Nakagawa et al. showed a case of a CS DAVF that shifted to the TS-SS after partial embolization of the SS combined with ligation of the internal jugular vein, 15 suggesting that the venous fl ow change could induce a new DAVF. Friedman et al. reported a case of posttraumatic DAVF with a fatal progression following multimodal treatments, partially because the initial treatment failed to completely obliterate the fi stula. 24 Our case is unique in that the CS DAVF recurred gradually and posteriorly following endovascular treatments. The mechanisms of newly formed DAVFs following endovascular treatments remain unclear. Several theories have been reported, including venous hypertension, 25 -27 a microcatheter and/or microguidewire manipulation, 4 maturation of an angiographically occult DAVFs, 16 and sinus thrombosis. 4 Recent studies have focused on the molecular mechanisms for the pathoetiology, and some clinical series have demonstrated that high levels of angiogenic growth factors, such as vascular endothelial growth factor and basic fi broblast growth factor, might be involved in the formation of DAVFs. 27, 28 In the present case, additional fi stulas may have developed in response to humoral factors produced by either the endovascular manipulations or the presence of the occult fi stula. Changes in the arterial and/or venous fl ow patterns, or development of sinus thrombosis after the treatment, could affect new DAVF formation. Decreased local arterial pressure may keep the dural arteriovenous shunts dormant, 27, 28 whereas the increased pressure after endovascular treatment could induce a new fi stula. In our case, the left CS DAVF drained into the ipsilateral paravertebral venous plexus. Venous hypertension resulting from stenotic change of the left internal jugular vein could have affected the recurrence of the DAVF. In addition, the endovascular manipulation might have changed venous fl ow patterns. Considering the recurrence in the left IPS, the fi stulas might therefore be incompletely embolized during the fi rst TVE despite the angiographically complete obliteration. Because there is little evidence regarding the pathogenesis for the recurrence of DAVFs, a further accumulation of cases is necessary. We therefore insist that careful follow-up is mandatory to check for the recurrence of CS DAVFs, especially in cases with venous fl ow changes, such as sinus occlusion, following endovascular treatment.
In conclusion, we presented a case of a CS DAVF recurring posteriorly even after the complete obliteration by TVE. Changes in venous fl ow patterns following endovascular treatments would be a risk factor for the recurrence of DAVFs.
